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ABSTRACT 
A Comparative Risk Metric of Infection from Exposure to Pathogens in 
Mespohilic Anaerobic Digested (MAD) Class B Biosolids 
Alrica Lincole Joe 
Patrick L. Gurian, Ph.D. 
 
 
 
Treated sewage sludge, also commonly known as biosolids, has been widely used in 
landscaping and farming.  Biosolids enhance the soil due to their high nutrient content 
and capacity to hold water.  However, biosolids may also contain pathogens that can 
threaten public health.  Digestion, lime stabilization, and composting are popular 
treatments used to reduce the pathogenic concentration.  In the United States, land 
application of Class B biosolids “is a routine undertaking to reuse sewage sludge” (Sen et 
al, 2009).   Class B biosolids are treated to reduce pathogens to low levels so that they 
pose minimal risk to public health and the environment.  There are a wide variety of 
pathogens potentially present in biosolids, and the hazards presented by these pathogens 
vary based on their initial concentration, survival time, and dose response behavior.  
Thus, the objective of this project was to develop a comparative metric for the risk of 
infection from exposure to current concentrations of pathogens in mesophilic, anaerobic 
digested (MAD) Class B biosolids through the ingestion pathway.  Various bacteria, 
viruses, and parasites were selected as pathogens of interest due to their risk of causing 
food and waterborne illnesses like gastroenteritis and infant diarrhea (Jones and Martin, 
2003).  Specifically, the aims of this research were to:  (1) compile the most current and 
accurate data on the occurrence, dose-response, and decay parameters for as many 
pathogens as possible; (2) prioritize and classify pathogens as high, medium, or low risk; 
(3) fit distributional plots to the risk metric; and (4) determine which parameter 
  x 
contributed the most to the overall uncertainty.  Results imply that special attention 
should be focused on Giardia, Adenovirus, Ascaris, Hepatitis A, and Rotavirus as they 
may present a high risk of infection if present in MAD Class B Biosolids.  Ingestion of 
protozoa and viruses at infectious doses can lead to gastroenteritis, respiratory illness, 
heart disease, and paralysis (Metcalf and Eddy, 2003; Haas et al., 1999; and Straub et al., 
1993).  A number of statistical distributions were evaluated for their ability to fit the 
calculated values of the metrics for different pathogens.  The Weibull model best fitted 
both the RRMO and RRM with ranges over seven and eight orders of magnitude, 
respectively.  Results also showed that dose-response and decay parameters contributed 
the most uncertainty to the risk metrics developed here.  Although occurrence was shown 
to not contribute as considerably as dose-response and decay, sufficient data to include 
occurrence in the assessment were available for only six pathogens. 
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CHAPTER 1:  INTRODUCTION AND REVIEW OF LITERATURE 
1.1 Statement of Problem 
In the United States, land application of Class B biosolids “is a routine undertaking to 
reuse sewage sludge” (Sen et al., 2009).  Class B biosolids undertaking consist of sludge 
that has been treated to reduce pathogens to low levels so that they pose minimal risk to 
public health and the environment.  Biosolids enhance the soil due to their high nutrient 
content and capacity to hold water.  It was projected that in 2010 approximately 8.2 
million dry tons of sewage sludge would be generated in the U.S. alone (Harrison et al., 
2003).  However, biosolids may also contain pathogens that can threaten public health.  
There are a wide variety of pathogens potentially present in biosolids, and the hazards 
presented by these pathogens vary based on their initial concentration, dose-response 
behavior, and survival in the environment. 
Digestion, lime stabilization, and composting are popular treatments used to reduce 
pathogenic concentrations.  As a result of effective sewage sludge treatment that has been 
established by the Environmental Protection Agency (EPA) since 1993, the occurrence of 
pathogens in Class B Biosolids has generally decreased.  “Traditional biosolids 
stabilization processes such as mesophilic anaerobic and aerobic digestion reduce 
pathogenic bacteria concentrations by 0.5 to 4 log10, viruses by 0.5 to 2 log10, and 
parasites by less than 0.5 log10 units” (Ahmed, 1997).  However, due to insufficient and 
antiquated data, parameters to quantify risk of infection from pathogens might have 
extensive uncertainty (Haas, 1999).  Most of the literature available on concentration, 
survival time, and dose response of pathogens in biosolids were published before the 
EPA “final rule for Standards for the Use and Disposal of Sewage Sludge” (Ahmed, 
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1997). Utilizing such data may not accurately portray the risk of infection from pathogens 
in Class B biosolids. 
1.2 Purpose of Research 
The focus of this research was to develop a comparative metric for the risk of infection 
from exposure to current concentrations of pathogens in mesophilic, anaerobic digested 
(MAD) Class B biosolids through the ingestion pathway.  Various bacteria, viruses, and 
parasites were selected as pathogens of interest due to their risk of causing food and 
waterborne illnesses like gastroenteritis and diarrhea (Jones and Martin, 2003).  
Specifically, the aims of this research were as follows:  (1) compile the most current and 
accurate data on the occurrence, dose-response, and decay parameters for as many 
pathogens as possible; (2) classify and prioritize pathogens as high, medium, or low risk; 
(3) fit distributional plots to the risk metric; and (4) determine which parameter 
contributed the most to the overall uncertainty.  
1.3 Definition of Biosolids 
Biosolids can be defined as the “solid, semisolid, or liquid” organic residues resulting 
from commercial, industrial, municipal wastewater treatment (Pepper et al., 2006; 
Department of Health and Human Services, 2002).  According to the National Research 
Council (NRC), biosolids are treated sewage sludge that meet the land application 
standards of the EPA Use or Disposal of Sewage Sludge (Code of Federal Regulations 
(CFR) 40 Part 503 Rule) (EPA, 1993).  This rule set numerical limits for pollutants, 
established operational standards for pathogens and reduction in odor and vector 
attraction, and management practices for the reuse and disposal of wastewater sludge 
(Metcalf and Eddy, 2003; NRC, 2002).  This sludge-derived product has similar 
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characteristics of soil-enhancing fertilizers.  Biosolids enhance the soil due to their rich 
nutrients like nitrogen, potassium, and phosphorous.  Biosolids exhibit the capacity to 
hold water in soil, and help to raise the pH of soil with the addition of lime kiln dust.  
These biosolids are created in an effort to sanitize water and sewages to meet the 
regulation standards of the 1972 Clean Water Act, before these waters are released into 
streams and rivers.  Although produced for a good cause, biosolids may become more 
toxic due to the increase in the degree of treatment of wastewater.  It may contain 
contaminants such as pathogens from human and animal feces and garbage grindings 
commonly found in household wastewater.  Biosolids may also contain toxic heavy 
metals, synthetic organic chemicals, as well as organic and inorganic waste from 
industrial and commercial facilities.  Safely disposing of biosolids in a manner that 
protects the public’s health and safety, and the environment is one of today’s major 
issues.   
1.3.1 Disposal Methods 
Communities are facing an increase in sewage sludge produced annually (Harrison et al, 
2002).  “Each person discharging human waste to a wastewater treatment system 
produces approximately 47 dry pounds (21 kilograms) of sewage sludge each year” (EPA 
1993).  EPA (2000a) projected that by 2016, the amount of wastewater released to public 
owned treatment works (POTWs) will increase by 88 percent.  This increase has led to 
intense research of possible disposal methods.  Some conventional methods have been 
banned by law or became difficult and expensive to maintain.  For example, many coastal 
areas used ocean dumping as the main source of disposal; however it was banned in the 
United States in 1988 by the Ocean Dumping Ban Act.  Many sludge incinerators were 
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used for some time, but they began to be recognized as major air polluters.  Other options 
are to reuse or recycle biosolids.  Heat-dried biosolids are emerging as a promising 
option.  Heat-dried biosolids have roughly the same heat value as low grade coal.  
Biosolids can be used as fuel for steam to generate electricity.  According to Amit Mor, 
CEO of Israeli investing and consulting firm Eco Energy, a ton of high-quality biosolids 
can produce about 30 kilograms, or 66 pounds, of good quality light oil (Kanellos, 2006).  
Other products such as methane, acetate, ethanol, and butyrate are being currently 
developed by bioconversion of biosolids (CWMI, 1996).  A more popular and cost 
effective use of biosolids is in land applications:  reclamation, land filling, and 
agriculture.  “It is estimated that approximately 5.6 million dry tons of sewage sludge are 
used or disposed of annually in the United States, of which approximately 60% are used 
for land application or public distribution” (NRC, 2002).  Biosolids work well in land 
application due to their similar characteristics to soil-enhancing fertilizers.  Land 
application of biosolids has been ongoing for several decades and continues to be 
supported by federal and state agencies due to its beneficial properties for landscaping 
and farming (EPA 1981, 1984, 1991).  Although beneficial to agriculture, biosolids may 
contain potentially harmful chemical pollutants and pathogenic organism.  Biosolids must 
be used in such a manner that balances benefits against acceptable effects on human 
health and the environment.   
1.3.2 Effective Biosolids Treatments 
Sludges from various wastewater treatments are required to be treated according to the 
land application standards of the 1993 U.S. EPA Part 503 Rule to produce biosolids 
suitable as to pose minimal threat to the public and environment.  Appendix A lists the 
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various unit operation, processes, or treatment methods utilized to process sludge.  
Treatment processes tend either remove moisture from the sludge or “stabilize the 
organic material” in sludge (Metcalf and Eddy, 2003).  Based on the processes used, a 
variety of solids are generated.  Types of solids produced are screenings, grit, 
scum/grease, raw sludge, primary sludge, chemically precipitated sludge, activated 
sludge, trickling-filter sludge, digested biosolids, and composted solids (Metcalf and 
Eddy, 2003).  Bitton et al. (1980) stated that toxic chemicals are not commonly found in 
biosolids. This is generally due to the physical and chemical pre-treatments processes 
required for wastewater.  Figure 1.1 and Figure 1.2 show a schematic of the general 
process of treating wastewater and sludge.  “However, pathogens that enter wastewater 
from infected individuals cannot be controlled at the source and are often concentrated in 
wastewater solids because of their density or through adsorption during wastewater 
treatment” (Ponugati, 1997). 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Wastewater Treatment Processes. The process schematic delineating water and 
wastewater treatment along with the sewage sludge stream. (NRC, 2002) 
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Reduction of pathogens absorbed in sludge can be accomplished by physical, chemical, 
and biological processes.  The following are required treatments in order to meet the EPA 
standards of land applied biosolids:  (1) Processes to Significantly Reduce Pathogens 
(PSRP) and (2) Processes to Further Reduce Pathogens (PFRP).  Tables 1.1 and 1.2 give 
brief descriptions of these processes.  PSRP reduce but do not eliminate pathogens, 
whereas PFRP reduce pathogens to levels below detection.  PSRP are regarded as 
stabilization processes that also reduce volatile or organic solids, unpleasant odor, and 
attraction to insects and rodents.  Biosolids treated by PSRP may still have the ability to 
spread infection (Metcalf and Eddy, 2003; NRC, 2002).  In addition, “stabilization is 
used for volume reduction, production of useable gas (methane), and improving the 
Figure 1.2 Sewage Sludge Treatment Alternatives. (NRC, 2002) 
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dewaterability of sludge” (Metcalf and Eddy, 2003).  PFRP are considered to be 
disinfection processes that enhance the results of stabilization (Lucero-Ramirez, 2000).   
Table 1.1 Processes to Significantly Reduce Pathogens (PSRP).a 
Process Description 
Facultative lagoons and 
storage 
Animal waste and manure is treated or stored in a lagoon 
system at a temperature of ≤5°C (≤34°F) for a period of at 
least 6 mo or at a temperature of >5°C (34°F) for a period of 
at least 4 mo. Because all wastes must be in a lagoon for the 
specified period, two lagoons probably will be needed so that 
while one is filling, the other can be aging. This avoids short-
circuiting. 
Air-drying 
Animal waste and manure is dried on sand beds or on paved 
or unpaved basins. The animal waste and manure dries for a 
minimum of 3 mo. During two of the three months, the 
ambient average daily temperature is above 0°C (32°F). 
Composting 
Using either the within-vessel, static aerated pile, or windrow 
composting methods, the temperature of the animal waste and 
manure is raised to 40°C (104°F) or higher and remains at 
40°C (104°F) or higher for 5 d. For 4 h during the 5-d period, 
the temperature in the compost pile exceeds 55°C (131°F). 
Anaerobic digestion 
Animal waste and manure is treated in the absence of air for a 
specific mean cell residence time (i.e., solids retention time) at 
a specific temperature. Values for the mean cell residence 
time and temperature shall be between 15 d at 35°C to 55°C 
(95 to 131°F) and 60 d at 20°C (68°F). 
Aerobic digestion 
Animal waste and manure is agitated with air or oxygen to 
maintain aerobic conditions for a specific mean cell residence 
time (i.e., solids retention time) at a specific temperature. 
Values for the mean cell residence time and temperature shall 
be between 40 d at 20°C (68°F) and 60 d at 15°C (59°F). 
Lime stabilization 
Sufficient lime is added to the animal waste and manure to 
raise the pH of the animal wastes and manure to 12 for ≥2 h of 
contact. 
 aEPA, 1993 
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Table 1.2. Processes to Further Reduce Pathogens (PFRP).a 
Process Description 
Composting 
Using within-vessel or static aerated pile composting, the 
temperature of the biosolids is maintained at 55°C 
(131°F) or higher for 3 d.  Using windrow composing, 
the temperature of the wastewater sludge is maintained at 
55°C (131°F) or higher for 15 d or longer.  During this 
period, a minimum of five windrow turnings is required. 
Heat-drying 
Dewatered biosolids are dried by direct or indirect 
contact with hot gases to reduce the moisture content to 
10 percent or lower.  Either the temperature of solids 
particles exceed 80°C (176°F) or the wet-bulb 
temperature of the gas stream in contact with the 
biosolids as the biosolids leave the dryer exceeds 80°C 
(176°F). 
Heat Treatment Liquid biosolids are heated to a temperature of 180°C (356°F) or higher for 30 min. 
Thermophilic Aerobic 
Digestion  
Liquid biosolids are agitated with air or oxygen to 
maintain aerobic conditions, and the MCRT is 10 d at 55 
to 60°C (131 to 140°F). 
Beta-ray Irradiation 
Biosolids are irradiated with beta rays from an 
accelerator at dosages of at least 1.0 megarad (Mrad) at 
room temperature (approximately 20°C (68°F)). 
Gamma-ray Irradiation 
Biosolids are irradiated with gamma rays from certain 
isotopes such as 60-cobalt or 135-cesium at dosages of at 
least 1.0 Mrad at room temperature (approximately 20°C 
(68°F)). 
Pasteurization The temperature range of the biosolids is maintained at 70°C (158°C) or higher for at least 30 min. 
 
 
aEPA, 1993 
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Of these processes, anaerobic digestion is the most widely and oldest process used to 
treat sludge.  Anaerobic digestion, through chemical and biological reactions, allows 
bacterial growth to occur in the absence of air.  This hydrolyzes organic materials, 
reduces volume of the biosolids, and destroys disease-causing pathogens.  One reaction, 
known as acidogenesis, is the fermentation of soluble organic compounds by acid-
producing facultative bacteria to produces carbon dioxide and some hydrogen gas 
(Lucero-Ramirez, 2000; Metcalf and Eddy, 2003).  Methanogenesis, another reaction, 
converts organic acids produced by anaerobic bacteria to mostly methane gas (Haug et 
al., 1998; Metcalf and Eddy, 2003).  The effectiveness of an anaerobic digestion process 
depends on the following factors:  (1) retention time, (3) temperature, (4) pH, (5) 
alkalinity concentrations, (6) availability of nutrients and trace metals for biological 
growth, and (7) inhibitory substances (Lucero-Ramirez, 2000; Metcalf and Eddy, 2003).  
Although each factor contributes to the overall success of anaerobic digestion, retention 
time and temperature are key aspects.  Adequate retention time is required to ensure 
efficient growth of bacteria and digestion of the sludge.  It the minimum retention time is 
not met, digestion will not proceed (WEF, 1998).  Temperature facilitates metabolic 
activity of microorganisms, gas transfer rates, and the settling of biological solids 
(Metcalf and Eddy, 2003).  Temperature influences the rate of digestion which 
establishes the minimum retention time.  Anaerobic digestion performs better in the 
thermophilic temperature range, between 50 and 57°C (120 and 135°F); however, “most 
anaerobic digestion systems are designed to operate in the mesophilic temperature range, 
between 30 and 38°C (85 and 100°F)” (Metcalf and Eddy, 2003).  The mesophilic range 
is more common because it requires less energy to heat and provides more stability.  The 
10 
 
final product of biosolids can be fashioned into cake, granular, pellet or liquid form.  
Based on the degree of treatment utilized, two classes of biosolids are produced:  Class A 
and Class B biosolids. 
1.3.3 Class A versus Class B Biosolids 
Class A and Class B biosolids are defined by the extent of treatment for pathogens 
including bacteria, enteric viruses, protozoa, and viable helminth ova.  Due to the 
difficulty of separating and identifying pathogens found in biosolids, indicator 
microorganisms can be used to detect the presence of pathogens.  Common indicator 
organisms that have been used are (1) total coliform bacteria, (2) fecal coliform bacteria, 
Escherichia coli (E. coli), bacteroides, fecal streptococci, enterococci, Clostridium 
perfringens, and coliphage.  Class A biosolids require a high level of treatment to reduce 
pathogen concentrations below detection levels. The EPA 40 CFR Part 503 requires that 
the following be met:  (1) fecal coliform density to be less than 1000 most probable 
number (MPN)/g of total solids (TS) , (2) Salmonella species (sp.) density to less than 3 
MPN/4 g of TS, (3) enteric viruses to less than 1 plaque-forming unit (PFU)/4 g of TS, 
and (4) viable helminth ova to less than 1 per 4 g of TS (EPA, 2000).  Biosolids that meet 
Class A pathogen requirements are safe to use on public and accessible land, such as golf 
courses and parks.  Class A biosolids that meet other regulations such as vector attraction 
reduction standards and heavy metal pollutant limits can be used as fertilizers or soil 
amendments without site restrictions.  They may be bagged and sold to individuals for 
lawn and garden care.  PFRPs that were previously mentioned are alternative treatments 
that may be used to reduce pathogens below detection levels.  Although pathogens levels 
are below detection, Class A biosolids are monitored and recorded as frequently 
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necessary.  In contrast, Class B biosolids receive lower levels of treatment and contain 
concentration of pathogens that pose minimal risk to public health and the environment.  
The EPA 40 CFR Part 503 requires fecal coliform densities of less than 2.0 × 106 MPN/g 
TS to be considered Class B biosolids.  Class B Biosolids are commonly generated by 
mesophilic anaerobic digestion (MAD) in the United States (Viau et al., 2009).  These 
biosolids must be used in accordance with site restrictions until pathogens are reduced 
further by environmental factors, such as sunlight and air.  Class B biosolids should not 
be sold to the public and can only be used in bulk on approved land sites such as 
agricultural lands, forests, and mine reclamation sites (NRC, 2002; Pepper et al., 2006).  
Biosolids that meet neither Class A nor Class B may also be used in landfilling and 
incineration if they meet the applicable requirements.  Although biosolids are mandated 
to be treated to standards so as to not pose a threat to the public, there have been reports 
of illness after exposure to field applied digested sludge.  Approximately 39 illnesses 
were reported from more than 328 residents; however, a causal connection has not been 
substantiated (Harrison et al., 2002).  Biosolids should be used in such a manner that 
balances against acceptable effects on human health and the environment.   
1.4 Pathogens of Concern 
Effective treatment of wastewater may concentrate pathogens in sludge.  Table 2.1 lists 
some of the pathogens that have been commonly found in Class B biosolids.  Such 
organisms are of interest due to their risk of causing food and water-borne illnesses like 
gastroenteritis and infant diarrhea (Jones and Martin, 2003).  These pathogens generally 
enter the environment from the runoff of land-applied livestock manure or the spread of 
feces of infected animals and humans (Gerba et al, 2005).  This list is non-exhaustive as it 
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is constantly changing.  Microorganisms continue to evolve and mutate, while new 
technologies in the detection of pathogens are becoming more advanced.  “Thus, no 
assessment of risks associated with the land application of sewage sludge can ever be 
considered complete when dealing with microorganisms” (Ponugoti et al., 1997).   
 
aPepper et al., 2006 
 
1.4.1 Bacteria 
Bacteria are considered to be prokaryotic, or organisms with no nucleus.  They vary in 
size from 0.3 to 2 µm and takes shapes such as rods (bacilli), spheres (cocci), and spirals 
(spirilla) (Metcalf and Eddy, 2003 and Haas et al., 1999).  There are two types of 
bacteria:  gram-positive (non-pathogenic) and gram-negative (pathogenic).  Bacteria are 
Table 1.3 Some Pathogens Commonly Found in Class B Biosolids.a 
Bacteria Protozoa Enteric viruses Helminth Ova 
Salmonella sp. 
Shigella sp. 
Yersinia 
Vibrio cholera 
Campylobacter jejuni 
Escherichia coli 
 
 
 
Crytosporidium 
 
Entamoeba histolytica 
 
Giardia lamblia 
 
Balantidium coli 
 
Toxoplasma gondii 
 
 
 
Hepatitis A virus 
 
Adenovirus 
 
Norovirus 
 
Sapporovirus 
 
Rotavirus 
 
Enteroviruses 
 
Reoviruses 
 
Astroviruses 
 
Hepatitis E virus 
 
Picobirnavirus 
 
Ascaris lumbricoides 
 
Ascaris suum 
 
Trichuris trichirua 
 
Toxocara canis 
 
Taenia saginata 
 
Taenia solium 
 
Necator americanus 
 
Hymenolepis nana 
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usually present inside the body in the intestinal tract and are removed through the 
excrement of feces.  They have the ability to infect humans and animals, but this is 
specific to certain strains of bacteria.  Infection and illness from pathogenic bacteria 
occurs by either killing healthy cells directly or releasing toxins from the lipid-
polysaccharides in their cell walls (Haas et al., 1999).  The most common and widely 
studied bacterium is wastewater treatment is Salmonella which is responsible for typhoid 
fever (Salmonella typhi) and salmonellosis or food poisoning (Salmonella paratyphy) 
(Gerba et al., 2005; Metcalf and Eddy, 2003; Haas et al., 1999; and Straub et al., 1993).  
Other bacteria isolated from raw wastewater include Shigella, Vibrio cholerae, Yersinia, 
Campylobacter jejuni, and Escherichia coli (pathogenic strain).  Shigella is known to 
infect only humans and cause bacillary dysentery.  Vibrio cholera causes cholera which 
has symptoms of heavy diarrhea and dehydration (Metcalf and Eddy, 2003).  Like 
Shigella, it is only known to infect humans generally through poorly sanitized water and 
is associated with the consumption of seafood.  Feachem et al. (1983) showed that Vibrio 
cholera can persist in wastewater at low temperatures for long periods of time.  This is 
probably due to the fact that the marine environment is its natural habitat (Haas et al., 
1999).  Yersinia, Campylobacter jejuni, and Escherichia coli are all known to cause 
gastroenteritis (Gerba et al., 2005).  Yersinia has been reported to infect animals and 
humans and occasionally cause yersiniosis, the clinical name for its gastroenteritis, in the 
United States (Straub et al., 1993).  It has been also reported to be found in raw, digested, 
and dewatered sludges (Metro, 1983).  Campylobacter jejuni has been considered to be 
more widespread than Salmonella and Shigella (Archer and Kvenberg, 1985) and has 
been documented to infect animals and humans.  E. coli are classified as opportunistic 
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pathogens which “are organisms that ordinarily do not cause disease in their natural 
habitat in normal health persons” (Haas et al., 1999).  Opportunistic pathogens pose the 
most danger to persons whose health has already been affected by previous conditions 
such as burns, open sores, diabetes, AIDS, etc. (Haas et al., 1999).  Pathogenic E. coli has 
been related to food and waterborne outbreaks (Feachem et al., 1983) and the O157:H 
strain is known to produce illness in humans (Haas et al., 1999).  Other opportunistic 
pathogens that have been associated with drinking water include Listeria and Legionella.  
They have been reported to cause meningitis and pneumonia or Legionnaire’s disease, 
respectively (Haas et al., 1999), but mostly in developing countries.    
1.4.2 Protozoa 
Protozoa are classified as eukaryotes, organisms with a nucleus, and are more complex 
than prokaryotes (Haas et al., 1999).  Some are non-pathogenic and naturally found in the 
environment, whereas others cause illnesses with symptoms such as diarrhea, stomach 
cramps, vomiting, nausea, and indigestion (Metacalf and Eddy, 2003).  Illness-causing 
protozoans that have been related to water and/or food contamination are categorized into 
five groups:  (1) ameobas (Rhizopoda), (2) flagellates (Mastlgohora), (3) ciliates 
(Cilratea), (4) Sporozoa, and (5) Microsporidia.  Of the protozoans, the following have 
been more recently associated with sewage:  Entamoeba histolytica, Giardia lamblia, 
Balantidium coli, and Cryptosporidium sp. (Straub et al., 1993).  These protozoans are 
clinically important because they only reproduce in the host, typically in the intestinal 
tract, and spread infection from the excrement of cysts or oocysts (Haas et al., 1999).  
Entamoeba histolytica, Giardia lamblia, and Balantidium coli produce cysts while 
Cryptosporidium produce oocysts.  Similar to E. coli, these protozoans have a 
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“significant impact on individuals with comprised immune systems” (Metcalf and Eddy, 
2003).  Oocysts are typically spherical in shape and range from 3 to 6 µm, whereas cysts 
can be spherical, semispherical, Ovid, tear drop, or kite-like, and range from 1 to 8 µm 
(Metcalf and Eddy, 2003).  Viability of the oocysts and cysts depends on their ability to 
encyst (open up and grow) through the stomach within 18 hours (Haas et al., 1999).  
Cryptosporidium sp. and Giardia lamblia are of significant importance because they can 
cause disease in both animals and humans, have been found in nearly all wastewater 
streams, and sometimes survive after traditional wastewater and biosolids treatments 
(Metcalf and Eddy, 2003 and Haas et al., 1999).  Their survival is attributed to their 
“protective structure called a pellicle” which covers the surrounding membrane (Haas et 
al., 1999).  
1.4.3 Enteric Viruses 
Enteric viruses are parasites that multiply or replicate in the intestinal tract and are 
released during the defecation of the infected host, either animal or human.  “Viruses are 
usually 200 nm or smaller and cannot be seen with a light microscope” (Haas et al., 
1999).  Over 120 different types of viruses have been identified to cause numerous 
diseases such as respiratory infection and illness, eye infections, congenital heart disease, 
meningitis, myocarditis, gastroenteritis, hepatitis, and paralysis (Haas et al., 1999 and 
Straub et al., 1993).  Enteroviruses, generally transmitted through aerosols and/or fecal 
matter, are the most commonly studied enteric viruses in sewage and sludge (Haas et al., 
1999 and Straub et al., 1993).  Enteroviruses include polio-, echo-, and coxsackie A- and 
B-, hepatitis A- and E-, reo-, rota-, and adenoviruses.  Rotavirus and Norovirus 
(gastroenteritis), and hepatitis E (respiratory illness) have been related to several 
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waterborne outbreaks (Gerba et al., 1984 and 1985; Straub et al., 1993; and Haas et al., 
1999).  Reoviruses and adenoviruses have been isolated in wastewater and are known to 
cause respiratory illness, gastroenteritis, and eye infections (Metcalf and Eddy, 2003). 
1.4.4 Helminth Ova 
Helminths are worms and those that cause infection to humans are generally nematodes 
(roundworms) or platyhelminthes (flatworms) (Metcalf and Eddy, 2003).  Helminth eggs, 
primarily the stage to cause human infection, range from 10 to 100 µm or more and can 
become concentrated in sludge (Metcalf and Eddy, 2003 and Feachem et al., 1983).  
Physical and chemical process such as sedimentation, filtration, and stabilization can 
reduce the concentration of helminth eggs in wastewater.  However, Ascaris eggs were 
reported to survive 10 years in sediments of oxidation ponds (Nelson et al., 2001 as cited 
by Metcalf and Eddy, 2003); while Taenia eggs were not completely inactivated by 
sludge treatment processes (Feachem et al., 1983).  Ascaris lumbricoides are roundworms 
that infect the small intestines (ascariasis) and are noted to be the most dominant parasite 
causing 1.5 billion infections worldwide (Crompton, 1999; Maier et al, 2000; and Roberts 
and Janovy, 1996 as cited by Metcalf and Eddy, 2003).  In the United States alone, 
approximately 4 million cases were reported (Khuroo, 1996).  Taenia saginata and T. 
solium are beef and pork tapeworms, respectively, which mainly cause illness from eating 
uncooked meat laden with tapeworm eggs (Straub et al., 1993).  Symptoms of infection 
include abdominal pain, weight loss, and digestive disturbances (Straub et al., 1983).  T. 
saginata tapeworms are the most popular in humans (Metcalf and Eddy, 2003).  Similar 
to the roundworm is the whipworm, Trichuris trichiura, which infects the large intestines 
(trichuriasis) with symptoms of abdominal pain and diarrhea, and damages the internal 
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organs with increasing concentrations (Straub et al, 1993).  Necator americanus and 
Ancyclostoma duodenale (hookworms) and Strongyloides stercoralis (threadworms) are 
other nematodes that cause human infection (Metcalf and Eddy, 2003).  N. americanus 
and A. duodenale generally infect the small intestines (ancyclostomiasis) with occasional 
symptoms of anemia and debility infection (Straub et al., 1993).  Feachem et al. (1983) 
indicated that hookworms tend to be less resistant than Ascaris eggs. 
1.4.5 Indicator Organisms 
Due to the difficulty of separating and identifying pathogens found in biosolids, indicator 
microorganisms can be used to detect the presence of pathogens.  An ideal indicator 
should meet the following criteria:  (1) consistently present when fecal contamination is 
present;(2) have an equal or greater presence than pathogens, (3) display the same 
resistance to the environment as pathogens, (4) cannot multiply outside the host 
organism, (5) possess faster, easier, and cheaper detection and quantification methods 
than pathogens, and (6) prone to be located in the intestinal tract of warm blooded 
animals (Cooper, 2001 and Maier et al., 2001 as cited by Metcalf and Eddy, 2003).  
Although no organisms have been found to exhibit all the characteristics of an ideal 
indicator, some of the organisms that have been used as surrogates for pathogens in 
biosolids include total and fecal coliform bacteria, E. coli, bacteriodes, fecal streptococci, 
enterococci, Clostridium perfringens, and coliphage.  Coliform bacteria are one of the 
most common indicators of fecal contamination.  This is due to fact that they are 
naturally located in the human intestinal tract and approximately 100 to 400 billion are 
released by each person a day (Metcalf and Eddy, 2003).  Fecal coliforms are a subset of 
total coliforms that can colonize at higher temperatures (45.5 ± 0.2°C) than total 
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coliforms (35 ± 0.5°C) (Metcalf and Eddy, 2003).  E. coli is another coliform bacterium 
that has been reported to be more indicative of fecal contamination (Metcalf and Eddy, 
2003).  Alternative bacterial indicators have become more popular due the limitations of 
coliforms.  Some concerns with coliforms have been their inability to detect the presence 
of enteric viruses and protozoa, short survival time, and possibility of regrowth outside 
the host organism (Metcalf and Eddy, 2003 and Sidhu and Toze, 2009).  Bacteriodes, 
fecal streptococci, and enterococci can differentiate between humans and animal feces 
which make them useful in fecal pollution source tracking (Siduh and Toze, 2009).  
Clostridium perfringens spores are used to indicate the presence of protozoa like 
Cryptosporidium and Giardia, but their effectiveness is disputable (Sidhu and Toze, 
2009).  Coliphage, mainly somatic and male-specific (F+), are members of 
bacteriophages which are used to indicate enteric viruses (Metcalf and Eddy, 2003 and 
Sidhu and Toze, 2009).  Since no one organism is perfect in determining the presence of 
pathogens in biosolids, it is suggested that a combination of indictor organisms proves 
more useful and effective (Straub et al., 1993). 
1.5 Hazardous Characteristics of Pathogens 
There are a wide variety of pathogens potentially present in biosolids, and the hazards 
presented by these pathogens vary based on their initial concentration, dose-response 
behavior, and survival.  To assess the hazards presented by pathogens, quantitative 
microbial risk assessment (QMRA) is used.  QMRA along with the general framework of 
risk assessment and its uncertainties are discussed in further detail in the next chapter.  
This section specifically focuses on three characteristics that make pathogens in biosolids 
hazardous. 
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1.5.1 Occurrence 
The occurrence of pathogens in wastewater treatment plants depends on season, climate, 
and sanitation (Straub et. al., 1993). With the progression in sanitation methods and 
continuous scrutiny of water quality standards, occurrence of pathogens in untreated 
sludge is expected to increase and become more concentrated.  This is due to the fact that 
“many microorganisms are known to survive better in wastewater when they are 
associated with the solid particles rather than in suspended state” (Sidhu and Toze, 2009).  
Ward et al. (1984) showed that various enteric viruses, Salmonella sp., Giardia sp., and 
Helminths typically ranged from 102 to 103 organisms/g of dry weight in treated 
secondary sludges.  The study also specified that indicators such as total and fecal 
coliforms ranged from 106 to 108 organisms/g of dry weight.  Anaerobic digestion 
produced Salmonella sp. densities of 0.8 to 33 MPN/g (Farrah and Bitton, 1984) and 
appeared to be ineffective on Ascaris in another study (Pedersen, 1981).  However, 
composting, a method denoted to further reduce pathogens, adequately reduced enteric 
viruses and helminth concentrations as to not pose a threat to human health (Yanko, 
1988).  A 3 to 4 log reduction in enteric viruses, indicator bacteria and possibly helminth 
can be expected from composting in the thermophilic temperature range (Straub et al., 
1993).  Composting does have the potential to support regrowth of pathogenic bacteria 
such as Salmonella sp., Yersinia enterocolitica and toxigenic E. coli (Yanko, 1988).  
Before the 1990s, detection and monitoring of pathogens in sludge was poorly conducted. 
There was lack of research on pathogen fate and transport as well as techniques to 
successfully recovery pathogens from the soil and water environment (Straub et al, 1993). 
Establishment of the EPA 1993 rule to disposal of sludge sparked much interest and 
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research continues to flourish in this field.  New technologies for the detection of 
pathogens and effective treatments to reduce pathogen concentration in biosolids have 
been conducted. For example, Chauret et al. (1999) studied the effectiveness of aerobic 
wastewater treatment and anaerobic digestion of sludge to reduce selected 
microorganisms and remove pathogenic protozoa in a wastewater treatment plant in 
Ottawa, Canada.  Samples were collected from raw and treated wastewater, primary 
effluent, mixed sludge, decanted liquor, and sludge cake.  Bacterial and somatic 
coliphage enumerations and fluorescent antibody staining were used to detect the 
presence of microorganisms and pathogens.  Results showed that all raw samples were 
positive for tested microorganisms, as well as Cryptosporidium oocysts and Giardia 
cysts. Aerobic treatment reduced Cryptosporidium oocysts and Giardia cysts by 2.96 and 
1.40 logs, respectively, in treated wastewater.  Clostridium perfringens spores and total 
count, somatic coliphage, and heterotrophic bacteria were reduced by approximately 
0.89, 0.96, 1.58 and 2.02 logs, respectively.  Remaining microorganisms had at least a 
3.53 log reduction.  Anaerobic digestion of the sludge, however, only reduced fecal 
coliforms and bacteria by mostly 2 logs.  Reduction of Cryptosporidium oocysts, Giardia 
cysts, Clostridium, and Enterococcus sp. were not statistically significantly reduced.  
Likewise, Graczyk et al. (2006) showed that Cryptosporidium oocysts, Giardia cysts, and 
human-virulent microsporidia spores were detectable in activated sewage sludge.  
Multiplex fluorescence in situ hybridization (FISH) assay and direct immunofluorescence 
assay were used to detect the pathogens. Cryptosporidium oocysts, Giardia cysts, and 
human-virulent microsporidia spores had an average concentration of 338 oocysts/liter 
(L), 843 cysts/L, and 224 spores/L, respectively.  Dewatering and biological stabilization 
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processes further reduced these concentrations to 88% less than in activated sludge.  
Guzman et al. (2007) looked at the persistence of helminth ova, Cryptosporidium sp., 
Salmonella spp., enteroviruses, and bacterial and viral indicators in raw and treated 
sludges.  Sludge treatment processes included mesophilic and thermophilic digestion and 
composting.  Low concentrations of helminth ova were detected in all samples, and 
viable Cryptosporidium oocysts were still present in treated sludges. Fecal coliforms, 
sulphite-reducing clostridia (SSRC), and somatic coliphages were the only indicators 
with values above their detection limits in most of the samples.  Results from these few 
current studies were similar to the densities of pathogen and indicators in secondary 
treated sludges.  A 2009 literature review was conducted by Sidhu and Toze that 
complied data on the occurrence of pathogens expected in biosolids.  It was noted that 
concentration of indicator organisms were anticipated to be 2 to 3 orders of magnitudes 
higher than that of pathogenic bacteria, while protozoan organisms were low (Sidhu and 
Toze, 2009).  Bacteriophage concentrations were similar to that of enteric viruses (Sidhu 
and Toze, 2009).  Although, the compilation was a great effort, Sidhu and Toze data 
mostly targets occurrence of biosolids outside the United States.  Only one reference 
(Dahab and Surampalli, 2002) provided information on the treatment of biosolids in the 
United States.  Dahab and Surampalli (2002) indicated that the concentration of fecal 
coliforms, fecal streptococcus, and Salmonella averaged approximately 3.6×107, 2.1×107, 
and 6.2×102 organisms/g in United Stated dried sludge. A more recent study was 
performed to reflect the advancement of sludge treatment in the United States.  Pepper et 
al. (2010) conducted “the first major study of its kind since the promulgation of the 
USEPA Part 503 Rule in 1993”. This research initially studied the occurrence of indicator 
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organisms and pathogens found in Class B Biosolids.  These biosolids were subjected to 
mesophilic, anaerobic digestion.  Twenty-one (21) samples were collected from 18 
different wastewater facilities in the United States.  Results showed that bacterial and 
viral pathogens in Class B biosolids were generally low; however adenoviruses were 
more common than enteric viruses.  High concentrations of both bacterial and viral 
indicator organism numbers were seen.  Toxigenic E. coli (E. coli 0157:H7), 
Campylobacter, and Ascaris ova were all below detection.  Secondly, the study reviewed 
the historic distributions of data from 1988 and 2006 at one location in Tucson, AZ. It 
was concluded that pathogens and indictor organisms reduced by 94 to 99% over the 18 
year period.  “Presumably this is due to better and more consistent treatment of the 
wastewater, illustrating that the Part 503 Rule has been effective in reducing public 
exposure to pathogens” in land applied biosolids (Pepper et al, 2010).  Although research 
support the fact that occurrence of pathogens has tended to decrease, pathogens are still 
being detected in some treated sludge samples.  Effective detection, identification, and 
removal are the only way to prevent the spread of pathogens in the environment and 
infection to the public from land applied biosolids.  
1.5.2 Dose-Response 
Paracelsus, a 16th century chemist and physician, first stated the often quoted “the dose 
makes the poison.”  This expresses the concept that the amount of exposure determines if 
there will be an adverse outcome.  Dose-response can be described as the relationship 
between the dose given and the elicited health effect.  Teunis et al. (1996) best explains 
the dose-response for a given effect as “the quantitative relation between the intensity of 
exposure (the dose) and the frequency of the occurrence of this effect within the exposed 
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population of hosts (the response)”.  Dose is the amount of chemical (or pathogen in this 
research) ultimately delivered to an organ tissue.  Microbial doses are based on methods 
“routinely used to count specific microbe in the laboratory” (Haas et al., 1999).  
Microbial dose can be expressed as colony-forming particles on agar media for bacteria, 
plaque-forming particles for viruses, and direct microscopic count of spores and (oo)cysts 
for protozoa (Teunis et al, 1996; Haas et al., 1999).  Dose-response curves are modeled 
with the logarithm of dose plotted against the level of response, which can be used in the 
threshold concept of no-effect levels (Haas, 1983).  Major routes of exposure to organ 
tissue include inhalation, ingestion, dermal, and injection.  Human and animal exposure 
to infectious pathogens is possible during land application of biosolids.  Aerosolized 
biosolids sprayed onto agricultural soil can effectively transport enteric microorganisms 
(Pahren and Jakubowski, 1980) and be inhaled from the wind and physically deposited 
onto the skin (Straub et al., 1993). Also, pathogens can be directly ingested by the 
consumption of soils amended with biosolids.  Indirectly, there is the potential to ingest 
contaminated ground water or near surface waters from leachate and runoff that may 
transport soil particles amended with biosolids (Straub et al., 1993).  Ingestion of 
pathogens, specifically a variety of bacteria, viruses, and parasites, can lead to food- and 
waterborne illness such as gastroenteritis.  Gastroenteritis is a major cause of disease and 
death worldwide and is mostly seen in young children in developing countries 
(Benenson, 1990).  In the United States, it is the most common waterborne illness and the 
second most common illness to cause acute disability (Craun, 1991 and Monto et al., 
1983).  An indication of infection is sometimes seen with symptoms such as diarrhea, 
fever, and vomiting; however, it is not necessary.  Usually with increasing dose, the 
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biological effect or response is greater.  The overall objective of a dose-response 
assessment is to determine the likelihood of a dose under real life conditions leading to 
infection or death.  This research is particularly interested in the possibility of infection 
given exposure to pathogen by ingestion of biosolids.  Modeling of dose-response 
relationships was first studied by Haas (1983) and subsequently thereafter (Rose et al., 
1991; Haas et al., 1993; and Regli et al., 1993).  Their research established the foundation 
of dose-response modeling and is still used today (Teunis et al., 1996; Haas et al., 1999; 
Soller et al., 2004; Armstrong et al., 2007; Smith et al., 2008; and Navarro et al., 2009).  
Dose-response models are determined from epidemiological studies on human subjects 
and toxicological studies of nonhuman subjects.  Under real life conditions, the dose to 
cause infection is relatively low and must be extrapolated from the high doses often 
utilized in these studies.  Exponential or Beta-Poisson models have been studied on 
various organisms and have shown to best-fit dose-response data (Haas, 1993).  These 
models are based on the assumption that organisms are randomly distributed within the 
consumed medium (biosolids) and follow a Poisson distribution.  This is due to the fact 
that “each organism has an independent and identical survival probability” to infect its 
host (Haas et al., 1999).  The exponential dose-response model can be expressed as the 
following: 
      R = 1 – e (-dose × r),            (1)  
where dose (organisms) is the amount of organisms swallowed and r (organisms-1) is the 
exponential dose-response parameter.  The Beta-Poisson model in microbial dose-
response relationships was derived by Furumoto and Mickey (1967, as cited by Haas et 
al., 1999) and is given by R = 1 - (1 + dose/β)-α, where α and β are the parameters to 
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adjust the model to fit dose-response data.  Variables that affect the dose are exposure 
concentration, length of exposure, and body weight of the exposed subject.  Much 
discussion has been on the time to onset effect.  Researchers have often reported the time 
needed to produce a given affect as either requiring a single dose or several doses to 
initiate infection (Blaser et al., 1982; Haas, 1983; and Rubin, 1987). It was concluded that 
exponential and Beta-Poisson models support the fact that “each microorganism is 
capable of infection” and are an improvement over the traditional lognormal model (Haas 
et al., 1999).  Another issue to consider is the use of animal models to extrapolate low 
doses and prolonged exposure times in humans.  A large sample size would be needed to 
determine the probability of infection at such low doses, and it would be extremely 
expensive “to provide adequate treatment to all the subjects involved” (Teunis et al., 
1996).  Extrapolation to low doses tends to overestimate risk in real-life situations 
making it a conservative, yet uncertain estimate.  As stated by Haas et al. (1999), more 
sufficient data from animals and humans is needed to accurately “address both hazard 
and dose-response, including virulence, strain variation and immunity, and multiple 
exposures”. 
1.5.3 Survival  
Survival of pathogens is one of the most important parameters in determining the hazard 
of pathogens.  In terms of biosolids, survival consists of the persistence of pathogens after 
physical, chemical, and biologically processes failed to inactivate pathogens.  Survival 
can be quantified as the rate of decay (k) in hours-1 or days-1.  Temperature is the key 
factor in determining survival of viruses, bacteria, protoza, and helminth (Straub, 1993).  
Ahmed and Sorensen (1995) studied the effects of stored digested and dewatered 
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biosolids to determine the kinetics of pathogen destruction.  Biosolids were collected 
from a wastewater treatment plant in central Utah.  Treatment processes consisted of 
primary settling, trickling filter, and aerobic and anaerobic digestion.  Biosolids were 
then stored for approximately 62 days to further reduce pathogens at various 
temperatures:  5, 22, 38, and 49.5°C (41, 72, 100, and 121°F).  Results showed that 
destruction of pathogens occurred at all temperatures examined; however, decay rates 
increased with increasing temperature. There was no significant difference between the 
destruction of pathogens under aerobic or anaerobic conditions at all temperatures 
studied.  At 50°C, the decay rate of S. typhimurium, Y. enterocolitica, bacteriophage f2, 
poliovirus, and Ascaris eggs was estimated to be 1.13, 1.10, 1.54, 0.81, and 0.21 log 
reduction/d-1, respectively. With viruses, soil moisture plays a role in its survival.  
Research has shown when high temperatures and evaporation decrease water content, 
rapid deactivation of viruses occurs (Gerba et al., 1981; Hurst et al., 1980a,b; Bitton et 
al., 1984; and Straub et al., 1992, 1993).  In addition to temperature, survival of bacteria 
is also influenced by bioavailability of nutrients, pH, and moisture.  These factors have 
the greatest impact on bacterial survival (Gerba et al., 1975).  Pepper et al. (1991) showed 
that bacterial indicator organisms were not detected on cotton farms until after land 
application of biosolids.  This could be attributed to Mallman and Litsky (1951) 
suggestion that sludge organic content may improve bacterial survival.  Helminth ova, 
specifically Ascaris eggs, have been determined to be the most persistent pathogen after 
land application (Cram, 1943; Jackson et al., 1977; and Meyer et al., 1978).  Composting 
of biowaste was studied to determine its effect on the survival of Listeria monocytogenes, 
Salmonella sp., and Escherichia coli (Lemunier et al., 2005).  E. coli and                         
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L. monocytogenes survived in compost up to 4 weeks old; however, strains of Salmonella 
survived in all composts at longer periods of time (up to 3 months).  Long-term storage of 
dewatered, digested and composted biosolids can be effective in reducing the risk of 
infection when average ambient air temperatures are 20°C (68°F) or higher. Increase in 
temperature of biosolids shortens the timeframe to prevent survival of pathogens and 
further improve the quality of the biosolids.  However, inappropriate storage during the 
winter months and deep burial of biosolids inhibit proper evaporation (Straub, 1993).  As 
a result, microbial risk assessments must be conducted with the most current data 
available and as little error as possible to properly protect human health and the 
environment. 
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CHAPTER 2:  RISK ASSESSMENT AND ITS UNCERTAINTEIS 
 
Risk assessment is defined as the “qualitative or quantitative characterization and 
estimation of potential adverse health effects associated with exposure of individuals or 
populations to hazards (materials or situations, physical, chemical and or microbial 
agents)” (Haas et al., 1999).  In simple terms, risk assessment tries to (1) identify the item 
that may potentially cause harm; (2) measure the likelihood of a negative outcome 
occurring; and (3) determine the magnitude of the effect the outcome could deliver.  Risk 
assessment is an entire concept within itself; however it falls under the umbrella of Risk 
analysis.  Risk analysis is also composed of risk management and risk communication.  
Risk management is the control of risks and generally involves selecting and 
implementing control measures.  It not only takes into consideration quantitative risks, 
but also policy making, ethics, engineering, and cost-benefits (Haas et al., 1999).  Risk 
communication is the exchange of scientific information in a balanced discussion among 
experts and the public.  These three concepts of risk analysis were initially assumed to be 
distinct entities with a firewall that separated assessment and management.  This was 
known as the “Red Book” approach that formally established the field of risk assessment 
in an environmental setting (NRC, 1983).  More recent studies by the NRC showed that 
this wall was impractical and that risk analysis should involve all “interested and affected 
parties” throughout the process (NRC, 1996).  Although the firewall is out, the 1983 
framework for risk assessment is still being used.  Figure 2.1 is a schematic of the risk 
assessment paradigm which involves a sequence of four steps.   
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The first step is hazard identification which focuses on pinpointing the hazard and its 
potential to cause harm.  It includes developing options for eliminating or substituting 
less toxic chemicals, hazard control measures, and responsible reuse or disposal of 
chemicals.  The second step is the exposure assessment which determines the 
concentration and intake rate of a contaminant to produce an adverse health effect and 
toxicity to an organism.  It also determines the pathways and duration of the exposure.  
The next step is the dose-response assessment which quantifies the occurrence of health 
effects based on the degree of exposure.  It is usually described as a mathematical 
expression which plots the response versus dose.  The last step is risk characterization 
which determines the severity of a hazard and its variability and uncertainty from the 
information in the previous three steps.  Risk assessment can be applied in different areas 
 
Figure 2.1 Schematic of the Risk Assessment Framework. 
Hazard 
Identification 
Exposure 
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such as finance, insurance, health and safety, and ecology.  This research is interested in 
health based risks which was best described by Gerba (c.2007). 
For these risks, the focus is on general human health, mainly outside the 
workplace.  Health-based risks typically involve high-probability, low-
consequence, chronic exposures whose long latency periods and delayed 
effects make cause-and-effect relationships difficult to establish.  This 
category also includes microbial risks, which usually have acute short-term 
effects.  However, the consequences of microbial infection can persist 
throughout an individual’s lifetime. 
To assess the hazards presented by pathogens, quantitative microbial risk assessment 
(QMRA) is used.  QMRA seeks to estimate the potential effects on human health 
associated with exposure to microbial agents.  QMRA identifies specific microorganisms 
and routes of exposure, develops dose-response models, examine host-microorganism 
interactions all while effectively incorporating epidemiological studies to assess the 
health of the exposed (Haas et. al., 1999). Risk assessment of microorganisms was 
initially studied in waterborne pathogens, especially due to the outbreak of infectious 
diseases and illnesses common in contaminated water.  These assessments yielded 
qualitative information on risks but did not explain the “microbial agents, their 
concentrations, distributions, and sources, and the potential for other serious or chronic 
health effects” (Haas et al., 1999).  Haas (1983), Rose et al. (1991), and Regli et al. 
(1991) were some of the first scientists to develop dose-response models and quantitative 
risks in in drinking water.  Microbial agents have become extremely important since the 
use of biosolids as fertilizer in farming and landscaping has increased over the past 20 
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years (Eisenberg et al., 2006).  As a means to protect the public health and the 
environment from the negative effects of pollutants in biosolids, the U.S. EPA 
established the final rule of the Part 503 Standards for the Use and Disposal of Sewage 
Sludge in 1993 (EPA, 1993).  Technological based standards and management and record 
keeping were the avenues used to limit pathogens in biosolids before the 1993 final rule.  
This rule allowed for limits on chemical compositions in biosolids to be based on 
quantitative risk assessment.  Microbial risk assessment techniques were thought to be 
novel and not properly developed.  However, “microbial risk assessment has progressed 
substantially in the past 15 years” (Haas et al., 1999; Eisenberg et al., 2002; and Soller et 
al., 2006).  The NRC suggested expanding risk assessment methods to institute more 
restrictive limits for chemical and pathogen in biosolids (NRC, 2000).  However, due to 
insufficient and antiquated data, parameters to quantify risk of infection from pathogens 
might have extensive uncertainty (Haas, 1999).  Limitation in the hazard identification 
step is due the unavailability of extensive epidemiological data, case studies, and disease 
investigations.  More “accurate methods for recovery, detection, quantification, 
sensitivity, specificity, virulence, and viability, as well as studies and models addressing 
transport and fate through the environment” are required to develop exhaustive databases 
for dose-response and exposure assessments (Haas et al., 1999).  Another source of 
uncertainty is the substitution of dose-response and occurrence of related microorganisms 
for new pathogens where data is non-existing.  Most of the literature available on 
concentration, survival time, and dose response of pathogens in biosolids were published 
before the EPA final rule for Standards for the Use and Disposal of Sewage Sludge 
(Ahmed, 1997).  Since 1993, occurrence of pathogens in Class B biosolids has generally 
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decreased; however, occurrence, a key element in determining exposure, has been 
attributed to render the most uncertainty in risk characterization (Haas et al., 1999). 
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CHAPTER 3:  METHODOLOGY 
3.1 Derivation of Relative Risk Metric Equations 
Recall Eq. (1) where risk R due to biosolids if ingested at time t = 0 days is R = 1 – e (-dose × r), 
where dose (organisms) is the amount of organisms swallowed and r (organisms-1) is the 
exponential dose-response.  A Taylor Series can be used to approximate the dose-response 
function when risk is low as R = r × dose, and dose can be expressed by C0 × Uptake, where 
C0 (organisms/gram (g)) is the pathogenic concentration in biosolids and Uptake (g/day (d)) 
is the amount of biosolids ingested per day.  Thus, low risk can be approximated as               
R = r × C0 × Uptake.  Supposing that a given exposure is repeated on a daily basis and 
pathogenic concentrations decay exponentially, risk at subsequent time periods may be 
expressed as  
R = r × C0 × Uptake × e-kt,      (2) 
where k (day-1) is the decay parameter.  Maintaining the assumption of low risks allows risks 
on subsequent days to be summed based on the following justification.  The union of two 
risks is the sum of the two risks minus the intersection.  For independent risks, the 
intersection will be the product of the two risks.  If both risks are small, then this intersection 
will be smaller still (e.g. if both risks are on the order of 10-2, then the intersection will be on 
the order of 10-4, or two orders of magnitude smaller).  The summation of risks over time 
may be carried out continuously by integration. Integrating Eq. (2) from t = 0 to t = ∞ yields 
the following: 
dtUptakeCr kt
t
t
)e(
0
0
−
∞=
=
×××∫  
= r ×C0 × Uptake dt
t
t
kt∫
∞=
=
−
0
e  
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       R = r × C0 × Uptake × k-1.     (3) 
Uptake can be omitted from Eq. (3) since this research is interested in a relative risk metric 
and uptake will be constant across different pathogens. This simplifies Eq. (3) to  
RRMO = r × C0 × k-1,       (4) 
where RRMO is the dimensionless relative risk metric conditioned on occurrence.  Given that 
data on occurrence of pathogens in biosolids after the 1993 EPA 40 CFR Part 503 is limited, 
an estimated risk metric without occurrence (RRM) can be determined by  
k
rRRM = .        (5) 
3.2 Criteria for Inclusion 
An extensive literature search was conducted to obtain numerical data on the three relative 
risk parameters mentioned in Eq. (4) for pathogens commonly found in Class B biosolids.  
Data for each parameter were selected only if appropriate descriptive statistics were 
available.  For concentration, this research specifically focused on mesophilic anaerobic 
digested (MAD) biosolids.  MAD treatment stabilizes biosolids in a temperature range 
between 30 and 38°C (85 and 100°F) (Metcalf and Eddy, 2003).  This method of treatment 
was selected because it is the “most widely used” system to reduce pathogenic concentrations 
(Ponugati, 1997).  Ward (1984) reported that bacteria concentrations are reduced by 0.5 to 4 
log10, viruses by 0.5 to 2 log10, and parasites by less than 0.5 log10 units when mesophilic 
anaerobic or aerobic digestion processes were utilized.  Only concentrations determined by 
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cell culture methods were selected.  Exponential or Beta-Poisson dose-response values based 
on human subjects were the most preferred.  However, animal dose-response values were 
utilized when human values were not available or did not include the required descriptive 
statistics.  Microbial decay values were collected from the best data available.  Values were 
based on decay in various water sources in suspended form and temperatures ranging from 0 
to 55° C (32 to 131°F).  Sources of water included but were not limited to rivers, 
groundwater, freshwater, wells, seawater, and distilled water.  Decay in effluent, composted 
manure, and soil were also used when applicable. 
3.3 Initial Calculations 
Initial calculations for all risk parameters included determining the 90th percentile upper 
bound (UB) or lower bound (LB) for each pathogen.  Other percentiles were calculated if 
confidence intervals were already indicated.  Figure 3.1 shows the process that was followed 
to identify values for each parameter.  Concentration and dose-response uncertainty was 
based on the upper bound (UB), whereas uncertainty for decay was based on the lower bound 
(LB).  If the UB or LB was not reported, a factor of 10 above or below the mean was applied 
to determine the UB and LB, respectively.  In the absence of a reported standard deviation (σ) 
for concentration, decay, and dose-response parameters, the following equation was used: 
σln = 
αZ
UB nominallnln − ,      (6) 
where nominal is the mean or central tendency, and Zα is the z-statistic (1 - α)  percentile.  If 
α was not given, a value of 0.1 was assumed.  These values will determine a conservative 
upper bound of calculated relative risks.  All concentration values were converted to 
organisms/g, if necessary.  As stated above, data for the dose-response parameter was 
preferred to be modeled as Exponential or Beta-Poisson as studies have shown that these 
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models tend to best-fit dose-response data (Haas, 1993).  Since this research focuses on low 
risk, the Beta-Poisson dose-response function can be approximated by a Taylor series as 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(α/β) × dose, where α and β are parameters for the Beta-Poisson model.  This is the same as 
the exponential low dose approximation given previously but with r = α/β.  Other dose-
response relationships were also used to estimate r when adequate.  If the mean dose (N50) or 
the mean lethal dose (LD50) was given, r was approximated from )( 5015.0 rLDe ×−−= .  When 
the exponential k was given, r was calculated as r = 1/k.  Once all descriptive statistics were 
Y
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back-calculate σ using 
appropriate equations 
NO 
Data Gap 
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Calculate UF 
Figure 3.1 Flowchart of Parameterization. 
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accounted for, the uncertainty factor (UF) was determined for each parameter when 
applicable as UF = UB/nominal or UF = LB × nominal.   
3.4 Point Estimated Risks 
An initial view of the relative risk of infection was determined for pathogens encompassing 
values for each risk parameter.  Mean concentration, dose-response, and decay values for 
qualifying pathogens were substituted into Eq. (4).  Based on the output generated for the 
RRMO, pathogens were classified as presenting high to low relative risk of infection.  
Subsequently, the RRM was calculated using the mean values of dose-response and decay 
parameters.  The 90 percent confidence intervals were determined for both risk metrics from 
the variance calculated in the next section.  Microsoft Excel 2010 was used to find the 
distribution that best fit the RRMO and the RRM. 
3.5 Uncertainty Analysis 
Uncertainty in the relative risk metrics was assessed analytically.  Taking the logs of both 
sides of Eq. (4) yielded ln RRMO = ln r + ln C0 - ln k.  Thus, the natural log of the RRMO is 
the sum of random variables and the variance of this sum is given by 
  ),cov(2),cov(2),cov(2 00
2
ln
2
ln
2
ln
2
ln 0
kCkrCrkCrRRMO +++++= σσσσ ,  (7) 
where cov is the covariance.  Since the random variables are independent, cov = 0, and thus 
these covariance terms are eliminated.  Therefore, Eq. (7) simplifies to  
2
ln
2
ln
2
ln
2
ln 0 kCrRRMO
σσσσ ++= .      (8) 
If all descriptive statistics were available for a particular parameter, values were log-
transformed and the standard deviation of the logs (σln) was back-calculated with Solver in 
Microsoft Excel 2010 using the following equation: 
.                  (9) 
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The solved σln was then squared to obtain the variance of the log-parameter.  If σ was not 
reported, σln for the parameter was back-calculated from Eq. 6 and then squared to obtain the 
variance.  Contribution of parameter with most uncertainty was determined as a percentage 
the parameter variance versus the risk metric variance: 
                         .             (10) 
 
The same was performed to determine uncertainty in the RRM.  Taking the logs of both sides 
of Eq. (5) yielded ln RRM = ln r - ln k.  Thus, the natural log of the RRM is the sum of 
random variables and the variance of this sum is given by  
    ),cov(22ln
2
ln
2
ln krkrRRMO ++= σσσ .              (11) 
Since the random variables are independent, the covariance term is eliminated and Eq. 11 
simplifies to Eq. 12: 
2
ln
2
ln
2
ln krRRM σσσ += .               (12) 
Identification of the parameter that contributed the most uncertainty in the RRM was also 
determined as a percentage of the variance of the risk parameters versus the variance of the 
RRM: 
                                       .             (13) 
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CHAPTER 4:  RESULTS AND DISCUSSION 
4.1. Collection of Numerical Data 
4.1.1. Occurrence 
Quantitative data was collected on the following parameters to determine the relative risk 
of infection from pathogens in Class B Biosolids:  (1) occurrence, (2) dose-response, and 
(3) decay.  Data on the occurrence of pathogens and indicators that met the required 
criteria were only available for 14 organisms.  Appendix B summarizes the reported 
literature on the occurrence of these pathogens.  Information was first obtained from the 
Pepper et al. (2010) study as it consisted of the most recent concentrations of several 
organisms in United States MAD biosolids, and immediate access to the original data was 
available.  From 2005 to 2008, 21 samples were collected from 18 treatment plants which 
catered to approximately 500,000 residents each around the county (Pepper et al., 2010).  
Pathogen concentrations were obtained from either cake (20% solids) or slurry (8% 
solids) samples using various assay methods, and were fitted to a lognormal distribution 
with maximum likelihood estimation (MLE) (Pepper et al., 2010).  Results showed that 
Campylobacter, E. coli O157:H, and Ascaris were non-detectable, while Shigella and 
enteric viruses were at low concentrations.  However, incidence of Adenovirus and 
indicator organisms such as fecal streptococci, Clostridium perfringens, fecal and total 
coliforms, and somatic Coliphage was high.  Statistical data on the occurrence of 
Cryptosporidium, Giardia, and E. coli were provided by Guzman et al. (2007), Chauret et 
al. (1999), and Wong et al. (2010), respectively.  In 2005, Guzman et al. (2007) analyzed 
six samples of incoming and outgoing sludges from two treatment plants in Barcelona, 
Spain.  Plant 1 was of interest as it consisted of a mixture of raw and secondary sludge 
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subjected to MAD for 20 to 25 days and produced a dewatered sludge of 25% dry matter 
(d.m.).  Mean concentration of viable Cryptosporidium oocysts was reported as 20 per 10 
g of d.m and ranged from 0.74 to 0.67 (Guzman et al., 2007).  It was believed that the 
max value given was a typo and rather should be 6.7 × 101 as research has shown that 
MAD yields a 1 to 2 log reduction of bacteria and viruses (Pedersen, 1981).  In 1995, 
Chauret et al. (1999) collected 10 semisolid cake samples of sludge also treated by MAD 
for 20 days from a wastewater treatment plant in Ottawa-Carleton, Canada.  Results for 
Giardia cysts showed a 1.40 log reduction with a mean average of 1.28 × 103 per 100 g 
of wet sludge (counts corrected to account for dewatering) (Chauret et al., 1995).  
Concentrations were as low as below detection to as high as 2.82 × 103 per 100 g.  Wong 
et al. (2010) collected 12 MAD biosolid samples from four wastewater treatment plants 
in Michigan from 2008 to 2009.  A log reduction of 1.5 was seen for E. coli with an 
extrapolated mean concentration of 3.16 × 103 organisms/g.  The concentration ranged 
from 6.05 to 1.12 × 106 organisms/g.  Each study mentioned above looked at the 
occurrence of similar organisms in MAD biosolids; however, only the most recent and 
useful values were selected for this research. 
4.1.2. Dose-Response 
Collection of data for the dose-response parameter was more successful than that of 
occurrence.  The numerical compilation of the data can be found in Appendix C.  Human 
exponential dose-responses were found for the following pathogens:  Cryptosporidium, 
Giardia, Adenovirus type 4, Hepatitis A virus, Astrovirus, and Norovirus (Haas et al., 
1999; Teunis et al., 1996; Couch et al., 1966; Ward et al., 1958; and Teunis et al., 2008).  
Viruses tend to fit exponential data well due to the low number of human subjects and 
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doses administered; however, protozoa like Cryptosporidium and Giardia fit regardless 
of the number of volunteers and doses (Haas et al., 1999).  Human dose-response data for 
Campylobacter, E. coli O157:H, Salmonella, Shigella, Vibrio cholerae, Ascaris, enteric 
viruses, and Rotavirus were reported to best-fit beta-Poisson models (Teunis et al., 1996; 
Powell et al., 2000; Teunis et al., 1999; Soller et al., 2004; Haas et al., 1999; Navarro et 
al., 2009; Ward et al., 1986; Regli et al., 1991; and Haas et al., 1993).  Enteric bacteria 
have a small α parameter ranging from 0.108 to 0.31 suggesting “a great heterogeneity in 
the distribution of host–pathogen infection probability” (Haas et al., 1999).  The dose-
responses of the remaining pathogens, Listeria, Yersinia, Hepatitis E virus, and 
Legionella, were all modeled using animal subjects such as primates, mice, and pigs (2), 
respectively (Smith et al., 2008; Lathem et al., 2005; Bouwknegt et al., 2009; and  
Armstrong and Haas, 2007).  Yersinia was fitted to a Beta-Poisson model, while the 
others to an exponential model.  Animal subjects were selected due to a lack of data on 
human dose-response for these pathogens.  Dose-responses of indicator organisms were 
not included in this study. 
4.1.3. Survival 
Survival times of pathogens in biosolids were scarce.  Adenovirus and Listeria were 
reported to actually survive in sludge and manure-compost, respectively.  Survival of 
Adenovirus type 4 was based on an average of Adenovirus types 40 and 41 which were 
stated to persist in secondary sewage effluent at 15°C (Enriquez et al., 1995).  Listeria, 
based on a study by Kim et al. (2010), was found to survive for 28 days in manure-
compost.  Similar to biosolids, Ascaris was found to persist in soil for three to four years 
(Jackson et al., 1977; Griffiths et al., 1978).  Survival of other pathogens and indicator 
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organisms has been extensively studied in various bodies of water.  In 1983, Feachem et 
al. showed that Entamoeba histolytica can survive in fresh water at a temperature range 
of 20-30°C for 15 to 30 days.  Helicobacter was also found to survive in fresh water at 
16-23°C (Adams et al., 2003) and at 25°C in the absence of light (Azevedo et al., 2008).  
Cook et al. (2007) and Ngazoa et al. (2007) studied the decay and survival of pathogens 
in river water.  It was reported that Campylobacter decays in underground river water, 
whereas Norovirus can survive at 4°C from a viral reduction at 20 and 30 days.  Research 
has shown that Clostridium perfringens, Yersinia, Astrovirus and Rotavirus survive in 
groundwater at various temperatures (Filip et al., 1988 and Espinosa et al., 2008).  
Likewise, it was found that Shigella tends to last in wells for approximately 22 days 
(Henis, 1987).  Cryptosporidium and Giardia have been known to persist in water from 
sediment experimentations at 23°C (Medema et al., 1998).  Koudela et al. (1999) and 
Ramaiah et al. (2004) studies showed that Microsporidia and Vibrio cholerae  can 
survive in distilled water at 4°C for two years and 75 days from starvation duration in 
natural, filtered seawater, respectively.  In general, the survival of pathogens at various 
temperatures has been broadly pursued.  Studies indicated that Salmonella and enteric 
viruses persist at 10-25°C (John et al., 2005 and Lyon and Faulkner, 2001).  At 0-10°C, 
Coliphage and Hepatitis A virus persists (John et al., 2005).  Literature was not found for 
the survival of Hepatitis E and its survival was assumed to be the same as Hepatitis A.  
Similar assumptions were applied to pathogenic E. coli O157:H  and indicator organism 
E. coli  to that of coliform bacteria survival at 3-37°C (John et al., 2005).  Enterococci 
have been assumed to be equivalent to fecal streptococcus, and its survival was studied 
by Keswick et al. (1982).  Lastly, it was found that Toxoplasma can survive at a higher 
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temperature range at 30-55°C (86-131°F) compared to the pathogens of interest in this 
study (Dubey et al., 1998).  Decay rates were approximated from the survival 
characteristics described above and are summarized in Appendix D. 
4.2. Point Estimated Relative Risks 
4.2.1. Relative Risk Metric Given Occurrence (RRMO) 
Much effort was put into the collection of data on the relative risk parameters.  However, 
due to the scarceness of data in each parameter, the relative risk given occurrence could 
only be computed for six pathogens commonly found in biosolids.  Figures 4.1 – 4.3 
illustrate the input data for the RRMO where the error bars are the UB and LB of the 
mean.  Figure 4.4 displays the results of the RRMO with its 90 percentile confidence 
interval.  Natural, distinctive breaks were discovered in the RRMO and were used to 
prioritize the relative risk of infection.  The RRMO results indicate that Adenovirus, 
relative to the other pathogens, may potentially present the highest concern given its 
RRMO value of 1.75 × 102.  However, Giardia may also be classified as having a high 
risk of infection as its RRMO value is 2.81.  Cryptosporidium, Shigella, and enteric 
viruses come in next presenting RRMO values of 2.21 × 10-1, 2.08 × 10-1 and 1.23 × 10-2, 
respectively.  Salmonella presents a low RRMO at 9.54 × 10-6.  Using Microsoft Excel 
2010, lognormal, gamma, and Weibull distributions were fitted to the RRMO by 
minimizing the squared differences between the model and input of the RRMO function.  
The Weibull model best fitted the RRMO and the alpha and beta parameter are 0.25 and 
1.01.  The 90 percent confidence interval ranged over seven orders of magnitude with the 
5th percentile at 5.60 × 10-6 and the 95th percentile at 9.00 × 101.  Figure 4.5 displays the 
cumulative probability distribution of the fitted Weibull model. 
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Figure 4.2 Dose-Responses of Pathogens for which Information on Occurrence in in MAD Class 
B Biosolids is Available.  The error bars indicate the 80 percent confidence interval unless otherwise 
denoted by * in which case the error bars indicate the 95 percent confidence interval. 
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Figure 4.1 Concentrations of Pathogens in MAD Class B Biosolids.  The error bars indicate the 80 
percent confidence interval. 
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Figure 4.3 Decay of Pathogens for which Information on Occurrence in MAD Class B Biosolids is 
Available.  The error bars indicate the 80 percent confidence interval. 
Figure 4.4 RRMO of Pathogens in MAD Class B Biosolids. The error bars indicate the 90 percent 
confidence intervals. 
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4.2.2. Relative Risk Metric (RRM) 
Relative risk of infection was also determined for 17 pathogens based solely on their 
dose-response and decay characteristics.  Figures 4.6 and 4.7 illustrate the RRM data 
inputs where the error bars are the UB and LB of the mean.  Figure 4.8 is the generated 
RRM with its 90th Percentile Confidence Intervals.  The RRM suggests that relative to the 
other pathogens, Ascaris may present the highest risk of infection.  Likewise, 
Adenovirus, Hepatitis A, and Rotavirus have a high risk relative to the other pathogens.  
These pathogens are classified as high risk because their RRM values are 5.16 × 101,   
2.26 × 101, 1.91 × 101, and 9.93, respectively. Cryptosporidium, Giardia, Campylobacter, 
Figure 4.5 Cumulative Probability Distribution of the Fitted Weibull to the RRMO. 
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Shigella, Vibrio cholerae, Yersinia, Enteric virus, Hepatitis E, and Norovirus pose a 
medium risk of infection.  E. coli O157:H, Listeria, Salmonella, and Astrovirus are 
deemed as potentially having a low risk of infection.  Adenovirus was classified as a high 
risk pathogen in both the RRMO and RRM.  This may be attributed to the greater 
concentration and dose-response parameters, and more persistence in the environment as 
compared to the bacteria, protozoa, and other viruses in this study.  In addition, the 
RRMO classified Giardia as a high risk of infection, while the RRM classified it as 
medium.  This shows the influence of occurrence data on risks.   
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Figure 4.6 Dose-Responses of Pathogens.  The error bars indicate the 80 percent confidence interval 
unless otherwise denoted by * in which case the error bars indicate the 95 percent confidence interval. 
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Figure 4.7 Decay of Pathogens.  The error bars indicate the 80 percent confidence interval unless 
otherwise denoted by * in which case the error bars indicate the 95 percent confidence interval. 
 
Figure 4.8 RRM of Pathogens.  The error bars indicate the 90 percent confidence intervals. 
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Using Microsoft Excel 2010, lognormal, gamma, and Weibull distributions were also 
fitted to the RRM by minimizing the squared difference between the model and input of 
the RRM function.  The Weibull model best fitted the RRM and the alpha and beta 
parameter are 0.22 and 0.40.  The 90 percent confidence interval ranged over eight orders 
of magnitude with the 5th percentile at 5.50 × 10-7 and the 95th percentile at 6.00 × 101.  
Figure 4.9 displays the cumulative probability distribution of the RRM.  Both risk metrics 
may not present an extremely accurate portray of risks of infection due to a number of 
uncertainties (i.e. factor of 10, number of samples detected, orders of magnitude variation 
in the 10th to 90th percentile ranges).  The next section discusses which risk parameter 
contributed the most uncertainty in calculating both the RRMO and RRM.  
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Figure 4.9 Cumulative Probability Distribution of the Fitted Weibull to the RRM. 
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4.3. Uncertainty Analysis 
4.3.1. RRMO 
The variance of each parameter was calculated and presented as percentage of the risk 
metric to exhibit uncertainty.  Results show that Salmonella had the most variance in its 
RRMO as compared to Cryptosporidium, Giardia, Shigella, Adenovirus, and enteric 
viruses (Figure 4.10).  The dose-response parameter contributed approximately 77% of 
uncertainty to the RRMO for Salmonella (Table 4.1).   
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Figure 4.10 Variance of RRMO in Natural Log-space. 
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The high percentage of uncertainty in dose-response for Salmonella is due to an 
uncertainty factor of 114.  Dose-response for Salmonella ranged from 7.10 × 10-7 to        
3.09 × 10-4, 3 orders of magnitude.  Adenovirus, which was classified as having the 
highest potential of risk of infection, had the lowest uncertainty in the RRMO.  The 
contribution of uncertainty was mostly attributed to its decay which had an uncertainty 
factor of 10.  The same reasoning can be applied to the high contributors of uncertainty 
for Shigella and Adenovirus.  This implies that more research is need in the area of dose-
response and decay.  However, for all pathogens in the RRMO, occurrence contributed 
the least amount uncertainty which suggests that data used for these pathogens was of 
good quality. 
 
 
 
 
 
 
 
Table 4.1 Percentage of Uncertainty Contribution for RRMO Risk Parameters. 
Pathogen Occurrence Dose-Response Decay 
Cryptosporidium 20.95 3.04 76.00 
Giardia 9.48 9.98 80.54 
Salmonella 10.70 77.35 11.96 
Shigella 31.81 34.10 34.10 
Adenovirus  0.25 12.58 87.17 
Enteric Virus 18.99 69.98 11.03 
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4.3.2. RRM 
Figure 4.11 and Table 4.2 show the variance of the RRM in natural log-space and the 
parameter that contributed the most uncertainty, respectively, for each pathogen.  Similar 
to the results of the RRMO, Salmonella still exhibited the highest variance in relative risk 
with 86% of its uncertainty contributed by its dose-response parameter.  Enteric virus 
showed the next highest variance with nearly 86% uncertainty from dose-response.  
Enteric virus dose-response had an uncertainty factor of 38.  Ascaris displayed the lowest 
variance in its RRM and almost 100% of its uncertainty was also due to its dose-response 
parameter. 
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Figure 4.11 Variance of RRM in Natural Log-space. 
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Table 4.2 Percentage of Uncertainty Contribution for RRM Risk Parameters. 
Pathogen Dose-Response Decay 
Cryptosporidium 3.85 96.15 
Giardia 11.02 88.98 
Campylobacter 77.17 22.83 
E. coli O157:H 65.22 34.78 
Listeria 39.43 60.57 
Salmonella 86.61 13.39 
Shigella 50.00 50.00 
Vibrio cholerae 10.38 89.62 
Yersinia 50.00 50.00 
Adenovirus 12.61 87.39 
Ascaris 99.55 0.45 
Enteric virus 86.38 13.62 
Hepatitis A 5.90 94.10 
Hepatitis E 48.06 51.94 
Astrovirus 50.00 50.00 
Norovirus 93.06 6.94 
Rotavirus 26.65 73.35 
 
 
Like Ascaris, Cryptosporidium, Giardia, Campylobacter, Vibrio cholerae, Adenovirus, 
Hepatitis A and Norovirus had similar variances.  For Campylobacter and Norovirus, 
dose-response accounted for 77% and 93%, respectively.  However, decay contributed 
the most uncertainty at 96%, 89%, 90%, 87%, and 94% for Cryptosporidium, Giardia, 
Vibrio cholerae, Adenovirus, and Hepatitis A, respectively.  It was assumed that the 
decay of Hepatitis E was the same as Hepatitis A; however, the results show that the 
decay parameter did not have the same effect of uncertainty.  Decay only contributed 
approximately 52% of uncertainty for Hepatitis E, while it contributed 94% for Hepatitis 
54 
 
A.  Uncertainty from dose-response was also nearly the same as that of decay for 
Hepatitis E.  
4.4. Conclusions and Further Work 
Based on the data current available in the literature, this research sought to prioritize and 
classify pathogens as high, medium, or low risk infection relative to one another, and 
determine which parameter contributed the most uncertainty.  Results imply that special 
attention should be focused on Giardia, Ascaris, Hepatitis A, Rotavirus, but especially 
Adenovirus, as they may present a high risk of infection if present in MAD Class B 
Biosolids.  Ingestion of protozoa and viruses at infectious doses can lead to 
gastroenteritis, respiratory illness, heart disease, and paralysis (Metcalf and Eddy, 2003; 
Haas et al., 1999; and Straub et al., 1993).  A number of statistical distributions were 
evaluated for their ability to fit the calculated values of the metrics for different 
pathogens.  The Weibull model best fitted both the RRMO and RRM with ranges over 
seven and eight orders of magnitude, respectively.  The large range shows the great 
variability in the risk that pathogens present.  The distribution of the risk metric considers 
the perspective in which different pathogens are drawn from an overall random 
distribution of pathogen risks.  This may assist in determining the relative risk of 
infection for pathogens not selected in this study.  Results also showed that dose-response 
and decay parameters contributed the most uncertainty in both the RRMO and RRM when 
determining the relative risks of infection from pathogens in MAD Class B Biosolids. 
There was a lack of information on the distribution of these parameters.  It was presumed 
that these values ranged from a factor of 10 below and above the mean which may have 
over-estimated the risk of infection.  Uncertainty in these parameters is also attributed to 
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the assumption that pathogens behave similarly to other pathogens in the same class (i.e. 
decay of Hepatitis E is the same as Hepatitis A).  Studies have shown that this is not 
always the case as organisms vary under different environmental conditions (Sidhu and 
Toze, 2009; Ahmed and Sorenson, 1997; Straub et al, 1993).  Although occurrence was 
shown to not contribute as considerably as dose-response and decay, sufficient data to 
include occurrence in the assessment were available for only six pathogens.  This study 
focused on the more general risk parameters that could be applied to any biosolids 
exposure scenario and does not consist of a detailed QMRA.  Consequently, this project 
gave insight on the prioritization of pathogens that have already been declared “of 
interest” in the land application of biosolids.  An in-depth QMRA, however, was 
performed by Kumar et al. (2011) which offer site- and scenario- specific results of risk 
of infection and illness.  This study took into consideration high exposure, uptake from 
different pathways, and the fate and transport of pathogens in land applied biosolids.  
Kumar et al. (2011) concluded that Adenovirus had the highest risk and incidental 
ingestion of biosolids appeared to be the pathway of most concern.  These results confirm 
the prioritization of this thesis.  This study may be utilized as a precursor to a full-blown 
QMRA to obtain a preliminary consensus of the risk of infection relative to other 
pathogens in land applied biosolids.  
More “accurate methods for recovery, detection, quantification, sensitivity, specificity, 
virulence, and viability, as well as studies and models addressing transport and fate 
through the environment” are required to develop exhaustive databases for the 
occurrence, dose-response and survival exposure assessments (Haas et al., 1999).  It is 
hoped that detection technologies and wastewater and biosolid treatments continue to 
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advance in order to keep up with the evolution of microorganisms and an increasing 
population.  With constant and effective treatment and management solutions, biosolids 
may continue to be reused in a manner that protects the public and the environment. 
Future work of this research includes collection of more statistical data ( occurrence, 
dose-response, and decay) on pathogens in MAD Class B Biosolids to help reduce 
uncertainty.  Also, statistical analysis should be conducted to determine if there is a 
significant difference between the RRMO and RRM, and if so, which metric will give the 
best estimate of relative risks. 
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APPENDIX A: SOLIDS PROCESSING METHODS 
 
Unit operation, unit process, or 
treatment method 
Function 
 
Pumping 
 
Transport of sludge and liquid biosolids 
 
Preliminary operations: 
     Grinding 
     Screening 
     Degritting 
     Blending 
     Storage 
 
 
Particle size reduction 
Removal of fibrous materials 
Grit removal 
Homogenization of solids streams 
Flow equalization 
 
Thickening: 
     Gravity Thickening 
     Flotation Thickening 
     Centrifugation 
     Gravity-belt Thickening 
     Rotary-drum Thickening 
 
 
Volume Reduction 
Volume Reduction 
Volume Reduction 
Volume Reduction 
Volume Reduction 
 
Stabilization: 
     Alkaline Stabilization 
     Anaerobic Digestion 
     Aerobic Digestion 
     Autothermal Aerobic Digestion (ATAD) 
     Composting 
 
 
Stabilization 
Stabilization, mass reduction 
Stabilization, mass reduction 
Stabilization, mass reduction 
Stabilization, product recovery 
 
Conditioning: 
     Chemical Conditioning 
     Other Condition Methods 
 
 
Improve dewaterability 
Improve dewaterability 
 
Dewatering: 
     Centrifuge 
     Belt-filter Press 
     Sludge Drying Beds 
     Reed Beds 
     Lagoons 
 
 
Volume reduction 
Volume reduction 
Volume reduction 
Storage, volume reduction 
Storage, volume reduction 
 
Heat Drying: 
     Direct Dryers 
     Indirect Dryers 
 
Weight and volume reduction 
Weight and volume reduction 
 
Incineration: 
     Multiple-hearth Incineration 
     Fluidized-bed Incineration 
     Coincineration with solid waste 
 
 
Volume reduction, resource recovery 
Volume reduction 
Volume reduction 
 
Application of biosolids to land: 
     Land Application 
     Dedicated Land Disposal 
     Landfilling 
 
 
Beneficial use, disposal 
Disposal, land reclamation 
Disposal 
 
Conveyance and storage 
 
Solids transport and storage 
aMetcalf and Eddy, 2003 
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 APPENDIX B:  COMPILATION OF OCCURRENCE OF PATHOGENS AND INDICATORS IN 
MAD CLASS B BIOSOLID† 
 
 
Pathogen Mean Standard Deviation LB UB Reference 
Cryptosporidiuma 2.00E+00b 2.57E+00 7.40E-02 6.70E+00 Guzman et al. (2007)  
Giardia c 1.28E+01d 1.62E+00 <2.50E-01 2.82E+01 Chauret et al. (1999)  
Campylobacterd,e <1.00E+00 2.00E-01 <1.00E+00 1.00E+01 Pepper et al. (2010)  
Clostridium perfringensd 4.16E+07 1.86E+08 3.98E+04 8.53E+08 Pepper et al. (2010)   
E. coli O157:Hd,e <1.00E+00 2.00E-01 <1.00E+00 1.00E+01 Pepper et al. (2010) 
Salmonellad,f 8.10E-01 2.60E+00 <2.50E-01 3.35E+00 Pepper et al. (2010) 
Shigellad,f 4.49E+00 5.37E+01 <1.00E+00 9.20E+00 Pepper et al. (2010)  
Adenovirusd 1.76E+01 1.33E+01 3.70E+00 2.26E+01 Pepper et al. (2010)  
Ascarisd,e <2.50E-01 5.00E-02 <2.50E-01 2.50E+00 Pepper et al. (2010) 
Coliphaged,f 2.09E+05 3.38E+12 <1.00E+00 1.92E+07 Pepper et al. (2010) 
Enteric virusd,f 1.05E-01 2.00E-01 <2.50E-01 8.00E-01 Pepper et al. (2010) 
Fecal coliformsd,f 1.27E+07 3.62E+07 5.17E+01 1.58E+08 Pepper et al. (2010)  
E. colid 3.16E+03 2.00E+01 6.05E+00 1.12E+06 Wong et al. (under review)  
Enterococcig 1.27E+04 3.20E+05 1.00E-20 3.15E+05 Pepper et al. (2010) 
†Concentrations are shown as organisms/g where the UB and LB are assumed to be the 80 percent confidence interval. 
a Viable oocysts. 
b Geometric mean and standard deviation. 
c Total cysts. 
d Arithmetic mean and standard deviation. 
e All values less than detection. 
f The MLE method used for mean and standard deviation because some values are below detection. 
g Utilized values of Fecal streptococcus. 
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APPENDIX C: COMPILATION OF THE DOSE-RESPONSE OF PATHOGENS IN MAD CLASS B BIOSOLIDS† 
 
Pathogen Mean Standard Deviation LB UB Reference 
Cryptosporidium††a,d  4.19E-03 1.43E+00 2.15E-03 7.57E-03 Haas et al. (1999); Teunis et al. (1996) 
Giardia††a,d 2.00E-02 1.88E+00 1.99E-02 5.66E-02 Teunis et al. (1996) 
Campylobacter††b,d 1.91E-02 1.99E-01 2.49E-04 1.34E-03 Teunis et al. (1996); Medema et al. (1996) 
E. coli O157:Hb,d 2.53E-05 6.03E+00 2.53E-06 2.53E-04 Powell et al. (2000) 
Listeria††a,g 1.76E-08 4.26E+00 1.62E-09 1.91E-07 Smith et al. (2008)  
Salmonellab,d 2.71E-06 4.03E+01 7.10E-07 3.09E-04 Teunis et al. (1999); Haas et al. (1999) 
Shigellab,d 4.90E-03 6.03E+00 4.90E-04 4.90E-02 As cited by Soller et al. (2004) 
Vibrio cholerae††b,d 1.54E-02 1.84E+00 9.18E-04 4.21E-02 Haas et al. (1999)   
Yersiniab,e 6.93E-05 6.03E+00 6.93E-06 6.93E-04 Lathem et al. (2005) 
Adenovirus type 4c,d 4.17E-01 6.03E+00 4.17E-02 1.00E+00 Couch et al. (1966) 
Ascarisb,d 9.49E-02 6.03E+00 9.49E-03 9.49E-01 Navarro et al. (2009)  
Enteric virusesb,d 1.40E-02 1.71E+01 8.80E-03 5.32E-01 Haas et al. (1999) 
Hepatitis A virusc,d,h 5.49E-01 6.03E+00 5.49E-02 1.00E+00 Ward et al. (1958) 
Hepatitis E virusa,f   1.30E-02 6.03E+00 1.30E-03 1.30E-01 Bouwknegt et al. (2009)  
Astrovirusc,d 6.06E-07 6.03E+00 6.06E-08 6.06E-06 Haas et al. (1999) 
Legionella a,f 6.00E-02 6.03E+00 6.00E-03 6.00E-01 Armstrong and Haas (2007) 
Norovirusa,d 2.78E-04 6.03E+00 2.78E-05 2.78E-03 Teunis et al. (2008)  
Rotavirusb,d 6.19E-01 2.95E+00 1.50E-01 1.00E+00 Ward et al. (1986); Regli et al. (1991);  Haas et al. (1993) 
† UB and LB were assumed to be the 80 percent confidence interval.                  d Based on human subject. 
††UB and LB were reported as the 95 percent confidence interval.                      e Based on mice subjects.                                                                                                                   
a Exponential dose-response.                                                                                  f Based on pig subjects.                                                                              
b Exponential dose-response estimated by Beta-Poisson parameters.                g Based on primate subjects. 
c Exponential dose-response estimated by exponential decay.                           h Dose in grams of feces of excreting infected individuals.                                  
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 APPENDIX D: COMPILATION OF THE DECAY OF PATHOGENS AND INDICATORS IN MAD CLASS B BIOSOLIDS† 
Pathogen Mean Standard Deviation LB UB Reference 
Cryptosporidium 3.79E-02 3.98E+00 3.79E-03 3.79E-01 Medema (1998) 
Entamoeba histolytica 1.15E-01 1.75E+01 7.68E-02 1.54E-01 Feachem (1983) 
Giardia 9.12E-02 3.98E+00 9.12E-03 9.12E-01 Medema (1998) 
Microsporidia 3.14E-03 3.98E+00 3.14E-04 3.14E-02 Koudela (1999) 
Campylobacter * 8.06E-01 6.22E-02 7.44E-01 8.69E-01 Cook (2007) 
Clostridium perfringens 6.00E-03 3.98E+00 6.00E-04 6.00E-02 Filip (1988) 
E. coli O157:H 6.91E-01 9.22E-01 2.30E-02 3.46E+00 John (2005) 
Helicobacter 5.88E+00 2.57E+00 3.36E-01 1.10E+01 Adams (2003); Azevedo (2008) 
Listeria 8.23E-02 3.98E+00 8.23E-03 8.23E-01 Kim (2010) 
Salmonella 2.30E-01 4.58E-01 6.91E-02 1.38E+00 John (2005) 
Shigella 1.06E-01 3.98E+00 1.06E-02 1.06E+00 Henis (1987) 
Vibrio cholerae 5.45E-02 3.98E+00 5.45E-03 5.45E-01 Ramaiah (2005) 
Yersinia 1.20E-02 3.98E+00 1.20E-03 1.20E-01 Filip (1988) 
Adenovirus type 4 4.20E-02 3.98E+00 4.20E-03 4.20E-01 Enriquez (1995) 
Ascaris 1.84E-03 2.13E+01 1.58E-03 2.10E-03 Jackson (1977); Griffiths (1978) 
Coliphage 6.91E-02 6.91E-02 5.52E-09 1.84E-01 John (2005) 
Enteric viruses 1.20E-01 7.78E+00 2.83E-02 1.44E+00 Lyon and Faulkner (2001) 
Hepatitis A virus 4.61E-02 9.22E-02 5.52E-09 1.84E-01 John (2005) 
Hepatitis E virus 4.61E-02 9.22E-02 5.52E-09 1.84E-01 John (2005) 
Astrovirus 5.76E-02 3.98E+00 5.76E-03 5.76E-01 Espinosa (2008) 
Norovirus 7.20E-03 1.47E+01 3.84E-03 1.05E-02 Ngazoa (2007) 
Rotavirus 2.74E-02 3.98E+00 2.74E-03 2.74E-01 Espinosa (2008) 
Toxoplasma 2.10E-01 3.84E+01 3.60E-02 3.84E-01 Dubey (1998) 
Fecal coliforms 4.51E-01 3.98E+00 4.51E-02 4.51E+00 McFeters (1974) 
E. coli 6.91E-01 9.22E-01 2.30E-02 3.46E+00 John (2005) 
Enterococci 5.28E-01 3.98E+00 5.28E-02 5.28E+00 Keswick (1982) 
† Units are presented as 1/day where the UB and LB were assumed to be the 90 percent confidence interval unless otherwise denoted by * in which case the 
UB and LB indicate the 95 percent confidence interval. 70 
